Brazil's health agency approves the use of two vaccines

Brazil’s health regulator on Sunday approved the urgent use of coronavirus vaccines made by Sinovac and AstraZeneca, enabling Latin America’s largest nation to begin an immunization program that’s been subject to delay and political disputes. Brazil currently has 6 million doses of Sinovac’s CoronaVac vaccine ready to distribute in the next few days and is awaiting the arrival of 2 million doses of the vaccine made by AstraZeneca and partner Oxford University. “This is good news for Brazil, but 6 million doses are still very few. It will not allow the entire population at risk to be fully immunized, nor is it clear how quickly the country will obtain more vaccines,” said Ethel Maciel, an epidemiologist at the Federal University of Espirito Santo.